XML 68 R59.htm IDEA: XBRL DOCUMENT v3.23.3
Balance Sheet Components - Schedule of Accrued and Other Current Liabilities (Detail) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Accrued Liabilities, Current [Abstract]    
Preclinical and clinical trial accruals $ 34,670 $ 57,780
API and bulk drug product price true-up 40,325 75,055
Litigation settlement 28,500 0
Payroll and related accruals 14,054 22,562
Accrued restructuring charge 4,694 0
Accrued co-promotion expenses - current 10,065 36,677
Roxadustat profit share to AstraZeneca 6,884 7,280
Property taxes and other taxes 7,950 7,691
Professional services 11,016 5,480
Current portion of liability related to sale of future revenues 5,860 0
Other 6,968 7,248
Total accrued and other current liabilities $ 170,986 $ 219,773